Ronit Regev

1.1k total citations
21 papers, 948 citations indexed

About

Ronit Regev is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ronit Regev has authored 21 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ronit Regev's work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacological Effects and Toxicity Studies (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). Ronit Regev is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Pharmacological Effects and Toxicity Studies (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). Ronit Regev collaborates with scholars based in Israel and Germany. Ronit Regev's co-authors include Gera D. Eytan, Yehuda G. Assaraf, Daniella Yeheskely‐Hayon, Y. Avi‐Dor, G D Eytan, Mario J. Borgnia, Irena Peri, Arnon Henn, Marko Ušaj and Naama Wiesel‐Motiuk and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Ronit Regev

21 papers receiving 926 citations

Peers

Countries citing papers authored by Ronit Regev

Since Specialization

Citations

This map shows the geographic impact of Ronit Regev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronit Regev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronit Regev more than expected).

Fields of papers citing papers by Ronit Regev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronit Regev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronit Regev. The network helps show where Ronit Regev may publish in the future.

Co-authorship network of co-authors of Ronit Regev

This figure shows the co-authorship network connecting the top 25 collaborators of Ronit Regev. A scholar is included among the top collaborators of Ronit Regev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronit Regev. Ronit Regev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overexpression and purification of human myosins from transiently and stably transfected suspension adapted HEK293SF-3F6 cells 2018 ·Analytical Biochemistry ·Marko Ušaj, (unknown), Ronit Regev, (unknown), Naama Wiesel‐Motiuk, Arnon Henn	4
2	N-terminal splicing extensions of the human MYO1C gene fine-tune the kinetics of the three full-length myosin IC isoforms 2017 ·Journal of Biological Chemistry ·(unknown), Ronit Regev, Marko Ušaj, P. Reinke, (unknown), Abraham O. Samson, Manuel H. Taft, Dietmar J. Manstein, Arnon Henn	14
3	Role of the plasma membrane leaflets in drug uptake and multidrug resistance 2010 ·FEBS Journal ·(unknown), Daniella Yeheskely‐Hayon, Ronit Regev, Gera D. Eytan	15
4	Competition between innate multidrug resistance and intracellular binding of rhodamine dyes 2008 ·FEBS Journal ·Daniella Yeheskely‐Hayon, Ronit Regev, (unknown), Gera D. Eytan	8
5	Modulation of P‐glycoprotein‐mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane 2007 ·FEBS Journal ·Ronit Regev, (unknown), Daniella Yeheskely‐Hayon, Gera D. Eytan	46
6	The tyrosine kinase inhibitors imatinib and AG957 reverse multidrug resistance in a chronic myelogenous leukemia cell line 2005 ·Leukemia Research ·Daniella Yeheskely‐Hayon, Ronit Regev, Gera D. Eytan, Eldad J. Dann	8
7	Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanism 2005 ·Biochemical Pharmacology ·Ronit Regev, Daniella Yeheskely‐Hayon, (unknown), Gera D. Eytan	83
8	Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1 2001 ·British Journal of Haematology ·Anne Carter, Eldad J. Dann, Tamar Katz, Yael Shechter, (unknown), Ronit Regev, Esther Eytan, Jacob M. Rowe, Gera D. Eytan	19
9	Membrane fluidization by ether, other anesthetics, and certain agents abolishes P‐glycoprotein ATPase activity and modulates efflux from multidrug‐resistant cells 1999 ·European Journal of Biochemistry ·Ronit Regev, Yehuda G. Assaraf, Gera D. Eytan	153
10	Familial perinatal hemochromatosis: A disease that causes recurrent non-immune hydrops 1999 ·Journal of Perinatal Medicine ·(unknown), T Dolfin, (unknown), Ronit Regev, Shmuel Arnon, D. Kidron	10
11	Efficiency of P‐glycoprotein–Mediated Exclusion of Rhodamine Dyes from Multidrug‐Resistant Cells is Determined by their Passive Transmembrane Movement Rate 1997 ·European Journal of Biochemistry ·Gera D. Eytan, Ronit Regev, (unknown), (unknown), Yehuda G. Assaraf	95
12	Flip-Flop of Doxorubicin across Erythrocyte and Lipid Membranes 1997 ·Biochemical Pharmacology ·Ronit Regev, Gera D. Eytan	75
13	Functional Reconstitution of P-glycoprotein Reveals an Apparent Near Stoichiometric Drug Transport to ATP Hydrolysis 1996 ·Journal of Biological Chemistry ·Gera D. Eytan, Ronit Regev, Yehuda G. Assaraf	85
14	The Role of Passive Transbilayer Drug Movement in Multidrug Resistance and Its Modulation 1996 ·Journal of Biological Chemistry ·Gera D. Eytan, Ronit Regev, (unknown), Yehuda G. Assaraf	160
15	Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein 1994 ·Journal of Biological Chemistry ·G D Eytan, Mario J. Borgnia, Ronit Regev, Yehuda G. Assaraf	41
16	Use of 23Na nuclear magnetic resonance spectroscopy to determine the true intracellular concentration of free sodium in a halophilic eubacterium 1991 ·Journal of Bacteriology ·(unknown), Michael H. Kogut, (unknown), Ronit Regev, Y. Avi‐Dor, Nicholas J. Russell	22
17	13C NMR study of the interrelation between synthesis and uptake of compatible solutes in two moderately halophilic eubacteria 1990 ·Archives of Biochemistry and Biophysics ·Ronit Regev, Irena Peri, (unknown), Y. Avi‐Dor	38
18	Growth Pattern in Krabbe's Disease 1986 ·Acta Paediatrica ·Joël Zlotogora, Ronit Regev, Shahar Hadar, T. C. Iancu	2
19	Krabbe disease: Increased incidence in a highly inbred community 1985 ·American Journal of Medical Genetics ·Joël Zlotogora, Ronit Regev, M. Zeigler, T. C. Iancu, Gideon Bach, John M. Opitz, James F. Reynolds	27
20	Prenatal diagnosis of krabbe disease using a fluorescent derivative of galactosylceramide 1984 ·Clinica Chimica Acta ·M. Zeigler, Joël Zlotogora, Ronit Regev, Arie Dagan, Shimon Gátt, Gideon Bach	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact